Introducing Invitae Digital Health–A Personalized Health Management Platform That Leverages Genomic Insights to Inform Health Decisions for Patients and Clinicians

– Invitae launches seamless digital platform to enhance patient and provider experiences and further bring genetics to mainstream medicine – SAN FRANCISCO, March 29, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of Invitae...

Click to view original post